Sinopharm Group Co. Ltd. (SHTDY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sinopharm Group Co. Ltd.

    OTC: SHTDY · Real-Time Price · USD
    11.97
    0.00 (0.03%)
    At close: Oct 03, 2025, 3:58 PM
    11.96
    -0.08%
    After-hours: Oct 02, 2025, 08:00 PM EDT

    Sinopharm Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 3.46B 3.35B 3.7B 4.95B 4.1B n/a 3.69B 4.18B 3.58B
    Depreciation & Amortization
    		 2.23B 2.4B 2.33B 2.31B 2.1B n/a 2B 1.9B 1.88B
    Stock-Based Compensation
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Working Capital
    		 n/a -5.46B 5.46B -2.04B 5.74B n/a -3.31B 1.03B -610.45M
    Other Non-Cash Items
    		 -39.8B -14.58B 14.34B -7.97B 22.36B 55.26B 8.98B 11.81B 16.59B
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 n/a 61.37B -61.37B 61.21B -71.89B n/a -48.97B 19.18B -49.83B
    Operating Cash Flow
    		 -34.11B 52.54B -40.99B 60.5B -43.33B 55.26B -34.29B 37.08B -27.77B
    Capital Expenditures
    		 -670.7M -1.44B -1.02B -1.24B -719.37M -945.08M -870.08M -1.28B -791.96M
    Cash Acquisitions
    		 n/a 102.01M -102.01M 42.54M -25.92M -233.31M -163.07M -263.92M -233.3M
    Purchase of Investments
    		 n/a n/a n/a 61.51M n/a 78.46M n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a -150.49M n/a -63.84M n/a n/a n/a
    Other Investing Acitivies
    		 139.46M -1.38B 86.63M -251.08M 1.93B -1.6B 1.42B 190.6M 1.11B
    Investing Cash Flow
    		 -531.24M -2.71B -1.04B -957.39M 1.18B -2.57B 391.02M -1.36B 88.3M
    Debt Repayment
    		 18.71B n/a 23.87B -25.18B n/a -15.61B n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 -2.14B -2.71B -2.34B -2.56B n/a n/a n/a -2.15B n/a
    Other Financial Acitivies
    		 -991.34M -36.12B 23.03M -1.2B 21.3B -7.8B 22.51B -24.4B 11.86B
    Financial Cash Flow
    		 15.58B -38.84B 21.55B -28.94B 21.3B -23.41B 22.51B -26.55B 11.86B
    Net Cash Flow
    		 35.24B -43.33B 43.33B 30.55B -20.84B 26.39B -11.38B 9.17B -15.82B
    Free Cash Flow
    		 -34.78B 51.1B -42.02B 59.26B -44.05B 51.45B -35.16B 35.79B -28.56B

    Add to Watchlist